Cargando…
Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial
BACKGROUND: Older patients at risk of functional decline are frequently affected by polypharmacy. This is associated with a further loss of independence. However, a relationship between functional disability and medications, such as ‘Potentially Inappropriate Medications’ (PIMs) and ‘Potential Presc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260981/ https://www.ncbi.nlm.nih.gov/pubmed/35799113 http://dx.doi.org/10.1186/s12877-022-03242-w |
_version_ | 1784742165172191232 |
---|---|
author | Salm, Claudia Sauer, Julia Binder, Nadine Pfefferle, Aline Sofroniou, Mario Metzner, Gloria Farin-Glattacker, Erik Voigt-Radloff, Sebastian Maun, Andy |
author_facet | Salm, Claudia Sauer, Julia Binder, Nadine Pfefferle, Aline Sofroniou, Mario Metzner, Gloria Farin-Glattacker, Erik Voigt-Radloff, Sebastian Maun, Andy |
author_sort | Salm, Claudia |
collection | PubMed |
description | BACKGROUND: Older patients at risk of functional decline are frequently affected by polypharmacy. This is associated with a further loss of independence. However, a relationship between functional disability and medications, such as ‘Potentially Inappropriate Medications’ (PIMs) and ‘Potential Prescribing Omissions’ (PPOs), as itemised for (de) prescribing in practice-orientated medication lists, has yet to be established. METHODS: As part of a randomised comparative effectiveness trial, LoChro, we conducted a cross-sectional analysis of the association between PIMs and PPOs measured using the ‘Screening Tool of Older Persons’ Prescription Criteria / Screening Tool To Alert to Right Treatment’ (STOPP/START) Version 2, with functional disability assessed using the ‘World Health Organization Disability Assessment Schedule 2.0’ (WHODAS). Individuals aged 65 and older at risk of loss of independence were recruited from the inpatient and outpatient departments of the local university hospital. Multiple linear regression analysis was used to model the potential prediction of functional disability using the numbers of PIMs and PPOs, adjusted for confounders including multimorbidity. RESULTS: Out of 461 patients, both the number of PIMs and the number of PPOs were significantly associated with an increase in WHODAS-score (Regression coefficients B 2.7 [95% confidence interval: 1.5-3.8] and 1.5 [95% confidence interval: 0.2-2.7], respectively). In WHODAS-score prediction modelling the contribution of the number of PIMs exceeded the one of multimorbidity (standardised coefficients beta: PIM 0.20; multimorbidity 0.13; PPO 0.10), whereas no significant association between the WHODAS-score and the number of medications was seen. 73.5 % (339) of the participants presented with at least one PIM, and 95.2% (439) with at least one PPO. The most common PIMs were proton pump inhibitors and analgesic medication, with frequent PPOs being pneumococcal and influenza vaccinations, as well as osteoporosis prophylaxis. CONCLUSIONS: The results indicate a relationship between inappropriate prescribing, both PIMs and PPOs, and functional disability, in older patients at risk of further decline. Long-term analysis may help clarify whether these patients benefit from interventions to reduce PIMs and PPOs. |
format | Online Article Text |
id | pubmed-9260981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92609812022-07-08 Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial Salm, Claudia Sauer, Julia Binder, Nadine Pfefferle, Aline Sofroniou, Mario Metzner, Gloria Farin-Glattacker, Erik Voigt-Radloff, Sebastian Maun, Andy BMC Geriatr Research BACKGROUND: Older patients at risk of functional decline are frequently affected by polypharmacy. This is associated with a further loss of independence. However, a relationship between functional disability and medications, such as ‘Potentially Inappropriate Medications’ (PIMs) and ‘Potential Prescribing Omissions’ (PPOs), as itemised for (de) prescribing in practice-orientated medication lists, has yet to be established. METHODS: As part of a randomised comparative effectiveness trial, LoChro, we conducted a cross-sectional analysis of the association between PIMs and PPOs measured using the ‘Screening Tool of Older Persons’ Prescription Criteria / Screening Tool To Alert to Right Treatment’ (STOPP/START) Version 2, with functional disability assessed using the ‘World Health Organization Disability Assessment Schedule 2.0’ (WHODAS). Individuals aged 65 and older at risk of loss of independence were recruited from the inpatient and outpatient departments of the local university hospital. Multiple linear regression analysis was used to model the potential prediction of functional disability using the numbers of PIMs and PPOs, adjusted for confounders including multimorbidity. RESULTS: Out of 461 patients, both the number of PIMs and the number of PPOs were significantly associated with an increase in WHODAS-score (Regression coefficients B 2.7 [95% confidence interval: 1.5-3.8] and 1.5 [95% confidence interval: 0.2-2.7], respectively). In WHODAS-score prediction modelling the contribution of the number of PIMs exceeded the one of multimorbidity (standardised coefficients beta: PIM 0.20; multimorbidity 0.13; PPO 0.10), whereas no significant association between the WHODAS-score and the number of medications was seen. 73.5 % (339) of the participants presented with at least one PIM, and 95.2% (439) with at least one PPO. The most common PIMs were proton pump inhibitors and analgesic medication, with frequent PPOs being pneumococcal and influenza vaccinations, as well as osteoporosis prophylaxis. CONCLUSIONS: The results indicate a relationship between inappropriate prescribing, both PIMs and PPOs, and functional disability, in older patients at risk of further decline. Long-term analysis may help clarify whether these patients benefit from interventions to reduce PIMs and PPOs. BioMed Central 2022-07-07 /pmc/articles/PMC9260981/ /pubmed/35799113 http://dx.doi.org/10.1186/s12877-022-03242-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Salm, Claudia Sauer, Julia Binder, Nadine Pfefferle, Aline Sofroniou, Mario Metzner, Gloria Farin-Glattacker, Erik Voigt-Radloff, Sebastian Maun, Andy Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial |
title | Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial |
title_full | Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial |
title_fullStr | Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial |
title_full_unstemmed | Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial |
title_short | Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial |
title_sort | over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260981/ https://www.ncbi.nlm.nih.gov/pubmed/35799113 http://dx.doi.org/10.1186/s12877-022-03242-w |
work_keys_str_mv | AT salmclaudia overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial AT sauerjulia overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial AT bindernadine overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial AT pfefferlealine overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial AT sofronioumario overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial AT metznergloria overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial AT faringlattackererik overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial AT voigtradloffsebastian overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial AT maunandy overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial |